Lyra - LYR

Lyra Therapeutics (NASDAQ:LYRA) Bolsa

Lyra Therapeutics

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

Binary,Options,Chart

Equities

News

Markets

APLD

GOOG

GOOGL

LYRA

TSLA

Meta Platforms, Applied Digital y Lyra Therapeutics brillaron ayer en Wall Street. ¿Qué impulsó estas subidas sorprendentes?

Applied Digital, Meta, Alphabet, Lyra Therapeutics, Tesla: 5 valores que están en el radar de los inversores

Lyra Therapeutics Inc

Management

BBAI

BigBear.ai Names Sean Ricker Interim Chief Financial Officer, Effective Immediately

Offerings

TIVC

Tivic Health Systems Inc Files For Resale Of 8.4M Shares Of Common Stock By Selling Stockholder

On June 6, 2025, Nektar Therapeutics (the "Company") filed a Certificate of Amendment to the Certificate of Incorporation of the Company (the "Increase in Authorized Shares Amendment") with the Secretary of State of the State of Delaware to increase the number of authorized shares of the Company's common stock, par value $0.0001 (the "Common Stock"), from 300,000,000 shares to 390,000,000 shares. The Increase in Authorized Shares Amendment was previously approved by the Company's stockholders at the Annual Meeting of Stockholders held on May 23, 2025 and became effective upon its filing.
&nbsp;
A copy of the Increase in Authorized Shares Amendment is filed as Exhibit 3.1 hereto and is incorporated herein by reference.
&nbsp;
On June 6, 2025, the Company also filed a Certificate of Amendment to the Certificate of Incorporation of the Company (the "Reverse Stock Split Amendment") with the Secretary of State of the State of Delaware to effect a reverse stock split of the Company's Common Stock at a ratio of one-for-fifteen (the "Reverse Stock Split"). The Reverse Stock Split Amendment provides that the Reverse Stock Split will become effective as of 11:59 p.m. Eastern Time on June 8, 2025 (the "Effective Time"), at which time every fifteen shares of the Company's Common Stock issued and outstanding immediately prior to the Effective Time will be automatically combined into one share of Common Stock. No fractional shares of Common Stock will be issued as a result of the Reverse Stock Split. Instead, any fractional shares resulting from the Reverse Stock Split will be rounded up at the participant level with The Depository Trust Company, if such shares of Common Stock are held directly or rounded down to the nearest whole share of Common Stock, if such shares are subject to an award granted under the 2017 Amended and Restated Performance Incentive Plan.
&nbsp;
Trading of the Company's common stock on a split-adjusted basis will begin at market open on June 9, 2025 under the existing symbol "NKTR" and new CUSIP number 640268306. The Reverse Stock Split will not change the number of authorized shares of the Company's Common Stock, which will remain at 390,000,000 shares following effect of the Increase in Authorized Shares Amendment.
&nbsp;
A copy of the Reverse Stock Split Amendment is filed as Exhibit 3.2 hereto and is incorporated herein by reference.

Stock Split

NKTR

Nektar Therapeutics Files Amendments To Increase Authorized Common Stock From 300M To 390M Shares And Implement 1-For-15 Reverse Stock Split Effective June 8, 2025; Split-Adjusted Trading To Begin June 9, 2025

Guidance

PLCE

Children's Place Says Results Remain Under Pressure Due To Current Macroeconomic Environment;For Fiscal 2025, We Expect To See Continued Top-line Sales Pressures

BRZE

Braze Files For Resale Of $3.9M Shares Of Class A Common Stock By Selling Stockholders

NOTE

FiscalNote Holdings Files For Offering Of Up To 12.5M Class A Common Stock By Selling Stockholder

LVWR

Livewire Group Tralisa Maraj Resigns As CFO Effective July 11, 2025

<a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1190935/000119312525137029/d191650d424b5.htm" title="https://www.sec.gov/ix?doc=/Archives/edgar/data/1190935/000119312525137029/d191650d424b5.htm">https://www.sec.gov/ix?doc=/Archives/edgar/data/1190935/000119312525137029/d191650d424b5.htm</a>

Pimco Announces $1B Offering

General

Asbury Automotive Group Expects Herb Chambers Deal To Close By July 2025

IOTR

iOThree Receives Nasdaq Notice For Non-Compliance With $1.00 Bid Price Requirement

The Oncology Institute Files For Stock Shelf Of Up to $50M

CAPT

Captivision Receives Staff Determination Notice From Nasdaq

MOVE

CORRECTION: Movano Announced Its Nasdaq Notification Of Deficiency On May, 23

Children's Place (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLCE#NASDAQ">PLCE</a>) reported quarterly losses of $(1.52) per share which missed the analyst consensus estimate of $(0.51) by 198.04 percent. This is a 28.81 percent decrease over losses of $(1.18) per share from the same period last year. The company reported quarterly sales of $242.13 million which missed the analyst consensus estimate of $260.62 million by 7.10 percent. This is a 9.61 percent decrease over sales of $267.88 million the same period last year.

Earnings

Earnings Misses

Children's Place Q1 Adj. EPS $(1.52) Misses $(0.51) Estimate, Sales $242.13M Miss $260.62M Estimate

Somnigroup International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SGI#NYSE">SGI</a>) has outperformed the market over the past 15 years by 2.71% on an annualized basis producing an average annual return of 14.7%. Currently, Somnigroup International has a market capitalization of $13.65 billion. 
Buying $100 In SGI: If an investor had bought $100 of SGI stock 15 years ago, it would be worth $796.47 today based on a price of $65.45 for SGI at the time of writing.
<h3>Somnigroup International's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749241823_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$100 Invested In Somnigroup International 15 Years Ago Would Be Worth This Much Today

WIIM

Nuveen Insured California Premium Fund Ii

Northann shares are trading higher amid ongoing volatility. The company announced  that it is not aware of any new material developments or pending announcements concerning its business operations that may be contributing to the recent volatile market activity.

Lazydays Holdings, Inc. (NASDAQCM: GORV) ("Lazydays" or the "Company") announced today that it has closed on the asset sale and real estate sale of its Ft. Pierce, Florida location to General R.V. Center, Inc. ("General RV"). The companies expect to complete the remaining divestiture in Longmont, Colorado in the coming weeks.

Asset Sales

GORV

Lazydays Closes Sale Of Ft. Pierce, FL Assets And Real Estate To General RV, With Longmont, CO Divestiture Expected In Coming Weeks

BrightView Holdings Enters Underwriting Agreement For 11.6M Shares Of Common Stock

Broadway Technology Inc ("Gaokai"), a leading manufacturer of high-quality PET (polyethylene terephthalate) cups and lids through its operating subsidiary Zhejiang Gaokai New Materials Co., Ltd., announced the execution of an Agreement and Plan of Merger (the "Merger Agreement") for a business combination with Quartzsea Acquisition Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QSEAU#NASDAQ">QSEAU</a>, QSEA, QSEAR))) ("Quartzsea"), a publicly traded special purpose acquisition company.
Upon consummation of the transaction contemplated by the Merger Agreement, (i) Quartzsea will be merged with and into Cuisine Universal Packaging Solution, a Cayman Islands exempted company and wholly owned subsidiary of Quartzsea ("Cuisine Universal") (the "SPAC Merger"), and (ii) concurrently with the SPAC merger, CUPS Sub Limited, a Cayman Islands exempted company and wholly owned subsidiary of Cuisine Universal, will be merged with and into Gaokai, resulting in Gaokai being a wholly owned subsidiary of Cuisine Universal (the "Business Combination" and the transactions in connection with the Business Combination collectively, the "Transaction"). Upon the closing of the Transaction, the combined company Cuisine Universal expects to be Nasdaq-listed under the ticker symbol "CUPS."

QSEA

QSEAU

Broadway Technology (Gaokai) Enters Merger Agreement With Quartzsea Acquisition Corp To Complete SPAC Business Combination; Combined Entity To Trade On Nasdaq As "CUPS" Under Cuisine Universal Structure

Despite fears of a sharp slowdown in the labor market, the official nonfarm payrolls report for May showed stronger-than-expected job growth, underscoring the resilience of the U.S. <a href="https://www.benzinga.com/news/econ-s">economy amid macroeconomic uncertainties.</a>
The economy added 139,000 nonfarm payrolls in May, beating expectations of 130,000 yet cooling <a href="https://www.benzinga.com/markets/economic-data/25/06/45812372/us-labor-markets-defies-tariff-concerns-as-nonfarm-payrolls-wages-top-expectations-in-may" target="_blank" rel="noopener">from the previous 147,000.</a> Wage growth also exceeded expectations, with average hourly earnings rising 0.4% month over month and 3.9% year over year. The unemployment rate remained steady at 4.2%.
President Donald Trump celebrated the strong May jobs report, calling the figures "great numbers," while renewing his public pressure on Fed Chair Jerome Powell, urging him <a href="https://www.benzinga.com/markets/economic-data/25/06/45818251/trump-cheers-strong-jobs-data-renews-attack-on-feds-powell-rates-should-be-much-lower">to lower interest rates.</a>
According to Trump, borrowing costs should be "much lower" as they are costing the U.S. economy "a fortune," suggesting the need to refinance maturing debt.
His remarks came after the Congressional Budget Office released updated estimates for Trump's sweeping tax bill, which is projected to add $2.4 trillion to the federal deficit over the next decade.
<h3 class="wp-block-heading">Political Spat Between Trump And Musk Hits Tesla Stock</h3>
A clash between Elon Musk and Trump <a href="https://www.benzinga.com/news/politics/25/06/45817556/trump-musk-feud-sends-betting-markets-into-overdrive-heres-what-traders-see-next">erupted on Thursday</a> after the tech billionaire publicly slammed the tax bill, claiming it was pushed through Congress too fast and never shared with him during his brief tenure as head of the Department of Government Efficiency.
Musk advocated for a leaner federal budget and accused the legislation of reckless spending.
Trump claimed Musk had gone crazy after losing access to government electric vehicle mandates. The president also floated the idea of scrapping all government contracts with Musk's companies, including SpaceX and Starlink, as a cost-saving measure for the budget.
Tensions reached a boiling point when Musk posted: "Time to drop the really big bomb: Trump is in the Epstein files. That is the real reason they have not been made public," yet offering no evidence to support the claim.
The feud sent shockwaves through markets, triggering Tesla Inc.&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) worst trading session of the year. Shares tumbled 14% on Thursday, erasing $152 billion in market value and capping a brutal week of double-digit losses.
On Friday, the S&amp;P 500 – tracked by the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) – closed at 6,000 points, gaining 1.5% for the week.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/06/45820264/top-2-alternatives-to-tesla-after-the-musk-trump-breakup">Top 2 Alternatives To Tesla After The Musk-Trump Breakup </a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Broad U.S. Equity ETFs

Global

Econ #s

ETFs

US Labor Market Shows Resilience, Tesla Slumps After Trump-Musk Feud: This Week In Markets

Press Releases

Lyra Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Lyra Therapeutics to Present Study Results for LYR-210 and LYR-220 in Two Presentations at the ARS and AAO-HNS Annual Meetings

Health Care

Lyra Therapeutics Fully Enrolls Pivotal Phase 3 ENLIGHTEN 2 Trial of LYR-210 for the Treatment of Chronic Rhinosinusitis

Lyra Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Incendia Therapeutics Appoints Bradford Smith as Chief Financial Officer

Lyra Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Lyra Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

Lyra Therapeutics to Present 52-week Extension Stage Results for ENLIGHTEN 1 Phase 3 Study for LYR-210 for the Treatment of Chronic Rhinosinusitis at COSM 2025

Analyst Ratings

Lyra Therapeutics Reports Positive Results from the ENLIGHTEN 2 Phase 3 Trial of LYR-210 Achieving Statistically Significant Results for Primary and Key Secondary Endpoints in the Treatment of Chronic Rhinosinusitis (CRS)

Comments

Lyra Therapeutics

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL